Editor's Summary Journals › Editorial Board. Volume 06, Issue 03. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. Editorial Board. Editor-in-Chief.

Novel scientific discoveries and new therapies that improve clinical outcomes for cardiovascular disease patients . The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. 2012 – 14). The journal covers all areas of translational medicine but also has several specialized sections: Cancer microenvironment - Edited by Davide Bedognetti Home > Editorial Board. Editorial Board (includes 3 members ... Department of Molecular Medicine University of Texas Health Science Center at San Antonio San Antonio, TX 78245-3207, USA : Yi-Ping Li, Ph.D. Jay McDonald Endowed Professor Department of Pathology The School of Medicine University of Alabama at Birmingham (UAB) Birmingham, Alabama 35294-2182, USA: Xinghua Lu, MD, PhD Professor, Dept. Xiangdong Wang, MD, PhD, is a Distinguished Professor of Medicine at Fudan University, Director of Shanghai Institute of Clinical Bioinformatics, and Executive Director of Zhongshan Hospital Institute of Clinical Science, Fudan University. Dr. Quest has more than 100 publications in international journals and is a member of the Editorial board of Cell Biology and Function (2013), Current Molecular Medicine (2014) and Biochemical Journal (2015). The Annals of Translational Medicine’s specific areas of interest include, but not limited to multimodality therapy, biomarkers, imaging, biology, pathology, and technical advances related to medicine. Since 2005 he is Full Professor at the same institution. Editorial Board xxx yyy yyy yyy In Press Current Issue Archive Submit Manuscript Publication Charges External Databases & Indexes. Editor's Summary ISI Journal Citation Reports @ Ranking: 2018: 42/136 (Medicine, Research & Experimental) Online ISSN: 1752-8062 Translational Medicine Communications is an interdisciplinary forum for all scientifically valid research from across translational medicine. If you are an administrator for Science Translational Medicine, please get in touch to find out how you can verify the contributions of your editorial board members and more. Editorial Board. 2012 – 14), divided by the number of documents in these three previous years (e.g. Editorial board members on Publons. Find out more about the editorial board for Chronic Diseases and Translational Medicine. 2012 – 14). CiteScore values are based on citation counts in a given year (e.g. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists. 2015) to documents published in three previous calendar years (e.g. The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Editorial Board Editor-in-Chief Xiangdong Wang, Fudan University, Shanghai, China. Publons users have indicated that they sit on Science Translational Medicine's editorial board but we are unable to verify these claims. … Ramaraj P. Editorial-Journal of Translational Science (JTS) May 27, 2019. Science Immunology 05 Jun 2020 IL-22 signaling limits oral candidiasis via proliferation of basal epithelial cells and replenishment of an IL-17–responsive layer.